IFP Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.1K Buy
827
+772
+1,404% +$21.7K ﹤0.01% 2885
2026
Q1
$1.57K Buy
55
+46
+511% +$1.57K ﹤0.01% 4048
2025
Q4
$356 Sell
9
-2
-18% -$73 ﹤0.01% 4361
2025
Q3
$388 Buy
+11
New +$379 ﹤0.01% 4248
2025
Q2
Sell
-18
Closed -$585 4199
2025
Q1
$581 Sell
18
-28
-61% -$1.04K ﹤0.01% 3426
2024
Q4
$1.41K Sell
46
-2,517
-98% -$81K ﹤0.01% 3207
2024
Q3
$71.9K Sell
2,563
-191
-7% -$4.71K ﹤0.01% 1559
2024
Q2
$62.7K Sell
2,754
-31
-1% -$715 ﹤0.01% 1567
2024
Q1
$84.7K Sell
2,785
-325
-10% -$10.9K ﹤0.01% 1357
2023
Q4
$111K Buy
3,110
+203
+7% +$7.55K 0.01% 1201
2023
Q3
$127K Sell
2,907
-14,651
-83% -$715K 0.01% 1155
2023
Q2
$867K Buy
17,558
+14,621
+498% +$674K 0.04% 469
2023
Q1
$71.1K Sell
2,937
-614
-17% -$25.5K ﹤0.01% 1411
2022
Q4
$89K Buy
3,551
+7
+0.2% +$292 ﹤0.01% 1816
2022
Q3
$89K Buy
3,544
+138
+4% +$6.31K ﹤0.01% 1937
2022
Q2
$86K Hold
3,406
﹤0.01% 1786
2022
Q1
$86K Buy
3,406
+888
+35% +$57.5K ﹤0.01% 1786
2021
Q4
$175K Sell
2,518
-6
-0.2% -$436 ﹤0.01% 1011
2021
Q3
$176K Buy
2,524
+200
+9% +$15.4K ﹤0.01% 1017
2021
Q2
$184K Sell
2,324
-1
-0% -$73 ﹤0.01% 943
2021
Q1
$152K Buy
2,325
+385
+20% +$23.7K ﹤0.01% 967
2020
Q4
$108K Buy
1,940
+905
+87% +$39.1K ﹤0.01% 1094
2020
Q3
$40K Buy
1,035
+307
+42% +$13K ﹤0.01% 1369
2020
Q2
$31K Buy
+728
New +$31.7K ﹤0.01% 1411
2016
Q1
Sell
-100
Closed -$2K 2422
2015
Q4
$2K Buy
+100
New +$2.06K ﹤0.01% 3296

Other funds holding ATRC

IFP Advisors's ATRC Position: Q2 2026 in Review

IFP Advisors increased its AtriCure (ATRC) stake by 1,404% in Q2 2026, buying an estimated $21.7K and bringing the position to 827 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2885.

IFP Advisors first reported a position in ATRC in Q4 2015 and has held it in 25 quarters since. The position peaked at $867K in Q2 2023. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • IFP Advisors held 827 shares of AtriCure worth $23.1K as of Q2 2026.
  • IFP Advisors bought 772 AtriCure shares in Q2 2026, an estimated $21.7K.
  • AtriCure made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2885 holding.
  • IFP Advisors first reported a position in AtriCure in Q4 2015 and has held it in 25 quarters since.
  • IFP Advisors's AtriCure position peaked at $867K in Q2 2023.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.